Recent findings by a team from the Salk Institute for Biological Studies have taken us one step closer to harnessing the body’s immune system to fight diseases like cancer and autoimmunity. Published in Nature Communications on November 6, 2023, the groundbreaking study led by Salk Professor Ye Zheng and Assistant Professor Jesse Dixon offers novel insights into the intricate workings of regulatory T cells and the pivotal role of the protein Foxp3 in their development and function.
Regulatory T Cells: The Body’s Own Peacekeepers
Regulatory T cells (Tregs) serve as crucial arbiters of immunological tolerance, preventing the immune system from turning on the body’s own cells. This ability to quell autoimmune responses also holds the key to potentially controlling how the immune system reacts to cancer cells. The differentiation and function of these cells are significantly influenced by chromatin architecture—the complex three-dimensional structure of chromosomes—and gene accessibility.
Foxp3: Sculptor of Immune Cell Identity
At the heart of the study is Foxp3, a protein long recognized for its role in Treg development. Yet, its involvement was once simplistically viewed as merely a genetic switch. Salk researchers posited a more comprehensive role for Foxp3, surmising its integral part in shaping chromatin architecture and thus Treg identity.
The collaborative effort between Zheng and Dixon mapped the 3D chromatin structures of Tregs, discovering that Foxp3 not only affects gene expression but is also essential for constructing the DNA loops crucial for Treg functionality. These loops bring genes vital for Treg identity into close proximity, enabling Foxp3 to effectively initiate the expression of these genes.
Reimagining the Role of Foxp3
Through meticulous comparison with effector T cells—Tregs’ functional counterparts which instigate immune responses—the study illustrates Foxp3’s unique involvement in Tregs. It turns out, Foxp3 is indispensable for creating the distinctive loops within the chromatin architecture, which are characteristic of Tregs.
This challenges the previous understanding that specialized pairs of Foxp3 proteins were necessary to form these loops. The discovery suggests that other complexes containing Foxp3 may contribute to this process, revealing a more intricate regulatory mechanism than previously appreciated.
Implications for Immunotherapy
These insights present a tantalizing opportunity for therapeutic intervention. “Now that we know Foxp3 plays a greater role in regulatory T cell function, we may be able to find ways to turn up and down Foxp3 to regulate immunosuppression,” says Dixon. By modulating the activity of Foxp3, it may be possible to increase immune tolerance to combat autoimmunity or decrease it to enhance the immune system’s ability to target cancer cells.
The Road Ahead
This pioneering research lays the groundwork for further studies into the interaction of Foxp3 with other proteins and the mechanistic intricacies behind DNA loop formation in Tregs. As understanding deepens, Foxp3 emerges as a promising target for therapies aimed at modulating the immune system’s response.
The study also underscores the importance of international and interdisciplinary collaboration, having been supported by agencies across the globe including the National Natural Science Foundation of China, the National Research Foundation of Korea, and institutions such as the NOMIS Foundation, the Crohn’s and Colitis Foundation, and the National Institutes of Health.
The Legacy of Salk Institute
The Salk Institute continues to live up to the legacy of its founder, Jonas Salk, by pushing the boundaries of discovery in multiple fields of biological research. Known for fostering a culture of bold and innovative research, the Institute is dedicated to understanding the very foundations of life and to solving some of the most pressing challenges facing humanity.
For more information on the transformative research at the Salk Institute, visit www.salk.edu.
/Public Release. The views expressed in this publication are those of the author(s) and do not necessarily reflect the positions or policies of the funding agencies or supporting institutions.